This is Neural Newscast. SpaceX prepares for its highly anticipated IPO, raising…
This is Neural Newscast. SpaceX prepares for its highly anticipated IPO, raising 75 billion dollars with a debut price of 135 dollars per share. This record-setting offering marks a significant milestone for the company and the Nasdaq. Meanwhile, a new pancreatic cancer drug may have revealed cancer master switch, opening the door to much longer survival times. And the Census Bureau has banned noise infusion from statistical products, a move that could affect how research data is published. Neural Newscast is AI-assisted, human reviewed. Find us at neuralnewscast dot com.